| By Frost and Sullivan |
| Wednesday, 06 May 2009 |
 |
The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the Global Active Pharmaceutical Ingredients (API) Market to be held on Wednesday, 6th May 2009, at 3 p.m. GMT. The API market, traditionally dominated by small molecule drugs, is currently witnessing a rapid shift towards biopharmaceuticals.
|
|
At the same time the manufacturing volume outsourced to contract manufacturing firms is on the rise. As plain vanilla generics continue to get highly competitive, API manufacturers are searching for newer avenues such as the production of high potency API's to differentiate themselves from competition.
Highlights of this briefing include an analysis of the global API market, challenges facing the global API industry, as well as market drivers and restraints, an estimate on the market size, and a look out on emerging trends.
The importance of the Asia-Pacific region as an API manufacturing hub will also be covered in this presentation.
This briefing will benefit API manufacturers, contract |
|
|
manufacturing companies, biotechnology as well as pharmaceutical companies, and the financial community wishing to understand the future potential of the API market.
"It is a difficult time for API manufacturers as they continue to battle challenges such as growing competition from low-cost countries and overcapacity.
Market participants will increasingly have to rely on strategies such as capability differentiation and consolidation to stay ahead of competition," observes Pharmaceutical & Biotechnology Programme Leader Sumanth Kambhammettu from Frost & Sullivan.
Frost & Sullivan will hold this conference call at 3 p.m. GMT on Wednesday, 6th May 2009, which will provide industry participants an outlook of the Global Active Pharmaceutical Ingredients (API) Market.
To participate, please email Katja Feick at katja.feick@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you. |
|
GIL 2009: Europe
Frost & Sullivan has expanded its flagship Global Congress on Corporate Growth - GIL Global - into several major cities around the world including London.
For the first time ever in Europe, Frost & Sullivan will be hosting the Growth, Innovation and Leadership Congress 'GIL 2009: Europe' on 19-20 May, at the Sofitel St James in London. GIL Global is the industry's only event designed to support senior executives in their efforts to achieve sustainable, top-line growth.
To register, obtain a programme agenda, explore sponsorship opportunities, or attend as a member of the media for GIL 2009: Europe, please contact Katja Feick, Corporate Communications Europe, at katja.feick@frost.com. One-on-One interviews with Frost & Sullivan senior growth consultants are also being scheduled.
Want to read more?
Aesica Acquires Third Major Manufacturing Facility
Aesica establishes US subsidiary to drive further growth in North America
Aesica opens office in China |
|
|
